| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 38.79M | 28.84M | 24.01M | 18.76M | 11.94M | 7.71M |
| Gross Profit | 13.46M | 10.96M | 10.37M | 8.61M | 6.15M | 5.58M |
| EBITDA | 1.86M | 2.03M | 1.40M | 1.34M | 960.00K | -196.00K |
| Net Income | -161.00 | 929.71K | 697.00K | 390.00K | 97.00K | -1.23M |
Balance Sheet | ||||||
| Total Assets | 24.78M | 16.84M | 14.49M | 13.86M | 11.29M | 11.09M |
| Cash, Cash Equivalents and Short-Term Investments | 501.39K | 523.27K | 1.22M | 1.17M | 902.00K | 2.10M |
| Total Debt | 3.25M | 184.23K | 383.00K | 563.00K | 690.00K | 665.00K |
| Total Liabilities | 9.67M | 5.05M | 3.83M | 4.43M | 3.18M | 3.30M |
| Stockholders Equity | 11.23M | 11.79M | 10.66M | 9.43M | 8.11M | 7.79M |
Cash Flow | ||||||
| Free Cash Flow | 470.18K | 1.16M | 338.00K | 445.00K | -1.08M | -569.00K |
| Operating Cash Flow | 1.61M | 1.49M | 2.13M | 1.55M | -227.00K | 90.00K |
| Investing Cash Flow | -2.48M | -1.92M | -1.80M | -1.10M | -852.00K | -338.00K |
| Financing Cash Flow | 1.36M | -207.73K | -257.00K | -225.00K | -164.00K | -7.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | £15.82M | 2.03 | 28.74% | 5.18% | ― | ― | |
70 Outperform | £9.96M | 7.16 | 9.46% | 4.73% | 6.76% | -11.53% | |
62 Neutral | £17.17M | -4.92 | 0.51% | ― | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | £7.38M | -7.59 | -1.88% | ― | -2.67% | -466.67% | |
44 Neutral | £8.89M | -2.50 | -34.87% | ― | -9.19% | 4.69% | |
42 Neutral | £11.39M | -3.44 | -14.44% | ― | 7.86% | 70.77% |